American Journal of Microbiological Research
ISSN (Print): 2328-4129 ISSN (Online): 2328-4137 Website: Editor-in-chief: Apply for this position
Open Access
Journal Browser
American Journal of Microbiological Research. 2021, 9(1), 14-24
DOI: 10.12691/ajmr-9-1-3
Open AccessArticle

Evaluation of Resistant Urinary Tract Infections by Gram-positive Bacteria in Medina, Saudi Arabia

Sahar Saad Allah Amin1, Nada A. Abdel-Aziz2, Wael S. El-Sayed3, 4, Manal Ibrahim Hanafi Mahmoud5, 6, Eman Mohamed Sharaf Elsayed7, 8 and Rehab A. Eltahlawi7, 9,

1Microbiology and Immunology Department, Faculty of Medicine, Ain Shams University, Egypt

2Medical Microbiology and Immunology Department, Faculty of Medicine, Suhag University, Egypt

3Biology Department, Faculty of Science, Taibah University, Medina, KSA

4Microbiology Department, Faculty of Science, Ain Shams University, Cairo, Egypt

5Department of Community Medicine, Ibn Sinai National College for Medical Studies, Jeddah, KSA

6Department of Community Medicine, Faculty of Medicine, Alexandria University, Egypt

7Department of Microbiology and Immunology, College of Medicine, Taibah University, Kingdom of Saudi Arabia

8Medical Parasitology Department, Faculty of Medicine, Zagazig University, Egypt

9Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Egypt

Pub. Date: March 18, 2021

Cite this paper:
Sahar Saad Allah Amin, Nada A. Abdel-Aziz, Wael S. El-Sayed, Manal Ibrahim Hanafi Mahmoud, Eman Mohamed Sharaf Elsayed and Rehab A. Eltahlawi. Evaluation of Resistant Urinary Tract Infections by Gram-positive Bacteria in Medina, Saudi Arabia. American Journal of Microbiological Research. 2021; 9(1):14-24. doi: 10.12691/ajmr-9-1-3


Background: Gram-positive uropathogens have become common, associated with serious underlying illnesses and increasingly resistant to available antibiotics. Objectives: The goal of this study was to investigate the incidence and risk factors of gram-positive cocci UTIs in hospitalized patients in Medina, KSA and their susceptibility patterns to widely used antimicrobial agents. Methods: During a 12-month study, 165 clinical isolates of gram-positive cocci were recovered from 1137 culture-positive urine specimens at a tertiary hospital. Antimicrobial susceptibility of gram-positive cocci isolates was tested with the disk diffusion and E test methods. Molecular typing of some VRE isolates was done to detect the predominant Van genotypes. Results: Out of 8600 reviewed cases, 1137 (13.2%) were culture positive, 165 cases (14.5%) were gram positive cocci. E.faecalis formed 53.3% (88/165) of isolated gram-positive cocci, followed by E faecium (17.6%), S.agalactiae (23.6%) and S. aureus (5.5%). Multidrug resistant positive cocci formed 9.7% of gram-positive isolates including VRE (8.5%) and MRSA (1.2%). 75% of E. faecalis and 50% of E. faecium isolates were sensitive to nitrofurantoin, all VRE strains were sensitive to linezolid. All S. aureus isolates were sensitive to cefazolin, nirtofurantoin, sulfamethoxazole and vancomycin. 75% of MRSA strains were sensitive to sulfamethoxazole and all were sensitive to vancomycin. All isolates of S. agalactiae were sensitive to cefazolin and nitrofurantoin, and all were resistant to Trimethoprim-sulfamethoxazole. Van B genotype was detected. Conclusion: Vancomycin and nitrofurantoin seem to be effective drugs for treatment of gram positive UTIs. vanB genotype was detected.

urinary tract infection gram positive bacteria antibiotic resistance genotyping

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Barišić Z, Babić-Erceg A, Borzić E, Zoranić V, Kaliterna V, Carev M. Urinary tract infections in South Croatia: aetiology and antimicrobial resistance. Int J Antimicrob Agents. 2003; 22: 61-4.
[2]  Prais D, Straussberg R, Avitzur Y, Nussinovitch M, Harel L, Amir J. Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection. Arch Dis Child. 2003; 88(3): 215-8.
[3]  Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002; 113(1): 53-70.
[4]  Mazzulli T. Resistance trends in urinary tract pathogens and impact on management. J Urol. 2002; 168(4 Part 2): 1720-2.
[5]  Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis. 2001; 7(2): 342.
[6]  Finer G, Landau D. Pathogenesis of urinary tract infections with normal female anatomy. Lancet Infect Dis. 2004; 4(10): 631-5.
[7]  Brook I. Urinary tract and genito‐urinary suppurative infections due to anaerobic bacteria. Int J Urol. 2004; 11(3): 133-41.
[8]  Le J, Briggs GG, McKeown A, Bustillo G. Urinary tract infections during pregnancy. Ann Pharmacother. 2004; 38(10): 1692-701.
[9]  Sefton AM. The impact of resistance on the management of urinary tract infections. Int J Antimicrob Agents. 2000; 16(4): 489-91.
[10]  Hryniewicz K, Szczypa K, Sulikowska A, Jankowski K, Betlejewska K, Hryniewicz W. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother. 2001; 47(6): 773-80.
[11]  Bonadio M, Meini M, Spitaleri P, Gigli C. Current microbiological and clinical aspects of urinary tract infections. Eur Urol. 2001; 40(4): 439-45.
[12]  Traub WH, Leonhard B. Agar disk diffusion (Bauer-Kirby) tests with various fastidious and nonfastidious reference (ATCC) strains: Comparison of several agar media. Chemotherapy. 1994; 40(6): 374-83.
[13]  Weinstein MP, Lewis JS. The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing: Background, Organization, Functions, and Processes. J Clin Microbiol. 2020; 58(3).
[14]  Bell JM, Paton JC, Turnidge J. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol. 1998; 36(8): 2187-90.
[15]  Perichon B, Reynolds P, Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother. 1997; 41(9): 2016-8.
[16]  Biosciences A. Isolation and antimicrobial susceptibility testing of Escherichia coli causing urinary tract infections. October. 2009; 22: 1320-5.
[17]  Assefa A, Asrat D, Woldeamanuel Y, Abdella A, Melesse T. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia. Ethiop Med J. 2008; 46(3): 227-35.
[18]  Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis. 2009; 13(2): 140-4.
[19]  Balkhy HH, Cunningham G, Chew FK, Francis C, Al Nakhli DJ, Almuneef MA, et al. Hospital-and community-acquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. Int J Infect Dis. 2006; 10(4): 326-33.
[20]  Angoti G, Goudarzi H, Hajizadeh M, Tabatabaii Z. Bacteria isolated from urinary tract infection among patients and determination of the antibiotic susceptibility patterns of the gram negative bacteria in Iran. Nov Biomed. 2016; 4(1): 1-4.
[21]  Raka L, Mulliqi-Osmani G, Berisha L, Begolli L, Omeragiq S, Parsons L, et al. Etiology and susceptibility of urinary tract isolates in Kosova. Int J Antimicrob Agents. 2004; 23: 2-5.
[22]  Wagenlehner FME, Naber KG. Current challenges in the treatment of complicated urinary tract infections and prostatitis. Clin Microbiol Infect. 2006; 12: 67-80.
[23]  Matthews SJ, Lancaster JW. Urinary tract infections in the elderly population. Am J Geriatr Pharmacother. 2011; 9(5): 286-309.
[24]  Esmaeili M. Antibiotics for causative microorganisms of urinary tract infections. 2005;
[25]  Mohammad-Jafari H, Saffar MJ, Nemate I, Khalilian HSA-R. Increasing antibiotic resistance among uropathogens isolated during years 2006-2009: impact on the empirical management. Int braz j urol. 2012; 38(1): 25-32.
[26]  Tessema B, Kassu A, Mulu A, Yismaw G. Pridominant isolates of urinary tract pathogens and their antimicrobial susceptiblity patterns in Gondar University Teaching Hospital, nothwest Ethiopia. Ethiop Med J. 2007; 45(1): 61.
[27]  Tayebi Z, Seyedjavadi SS, Goudarzi M, Rahimi MK, Boromandi S, Bostanabad SZ, et al. Frequency and antibiotic resistance pattern in gram positive uropathogenes isolated from hospitalized patients with urinary tract infection in Tehran. Iran J Genes Microb Immun. 2014; 2014: 1-9.
[28]  Mansoor IY, AL-Otraqchi KIB, Saeed CH. Prevalence of urinary tract infections and antibiotics susceptibility pattern among infants and young children in Erbil city. Zanco J Med Sci. 2015; 19(1): 915-22.
[29]  Kanellopoulos TA, Salakos C, Spiliopoulou I, Ellina A, Nikolakopoulou NM, Papanastasiou DA. First urinary tract infection in neonates, infants and young children: a comparative study. Pediatr Nephrol. 2006; 21(8): 1131-7.
[30]  Yilmaz Y, Tazegun ZT, Aydin E, Dulger M. Bacterial uropathogens causing urinary tract infection and their resistance patterns among children in Turkey. Iran Red Crescent Med J. 2016; 18(6).
[31]  Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J. 2008; 27(4): 302-8.
[32]  Sivaraj P, Pradhan S, Beriha S, Barik R, Tago N, Das L, et al. Study of risk factors associated with febrile urinary tract infection in children. Sri Lanka J Child Heal. 2015; 44(3).
[33]  Korbel L, Howell M, Spencer JD. The clinical diagnosis and management of urinary tract infections in children and adolescents. Paediatr Int Child Health. 2017; 37(4): 273-9.
[34]  Shrestha LB, Baral R, Poudel P, Khanal B. Clinical, etiological and antimicrobial susceptibility profile of pediatric urinary tract infections in a tertiary care hospital of Nepal. BMC Pediatr. 2019; 19(1): 36.
[35]  Sakran W, Miron D, Halevy R, Colodner R, Smolkin V, Koren A. Community acquired urinary tract infection among hospitalized children in northern Israel: pathogens, susceptibility patterns and urinary tract anomalies. Harefuah. 2003; 142(4): 249-52.
[36]  Glover M, Moreira CG, Sperandio V, Zimmern P. Recurrent urinary tract infections in healthy and nonpregnant women. Urol Sci. 2014; 25(1): 1-8.
[37]  Easter SR, Cantonwine DE, Zera CA, Lim K-H, Parry SI, McElrath TF. Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia. Am J Obstet Gynecol. 2016; 214(3): 387-e1.
[38]  Marzieh J, Mohsen S, Nasrin R, Koroosh K. Prevalence of urinary tract infection and somes factors affected in pregnant women in Iran, Karaj. Middle-East J Sci Res. 2014; 20(7): 782-5.
[39]  Labi AK, Yawson AE, Ganyaglo GY, Newman MJ. Prevalence and associated risk factors of asymptomatic bacteriuria in ante-natal clients in a large teaching hospital in Ghana. Ghana Med J. 2015; 49(3): 154-8.
[40]  Khoshbakht R, Salimi A, SHIRZAD AH, Keshavarzi H. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Karaj, Iran. 2013;
[41]  von Eiff C, Proctor RA, Peters G. Coagulase-negative staphylococci: pathogens have major role in nosocomial infections. Postgrad Med. 2001; 110(4): 63-76.
[42]  Al-Tawfiq JA, Anani AA. Antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infections in a Saudi Arabian hospital. Chemotherapy. 2009; 55(2): 127-31.
[43]  Sheikholeslami NZ, Hassanshahi G. The frequency of coagulase negative staphylococci urinary infections with antimicrobial resistance pattern in Rafsanjan. Pakistan J Med Sci. 2010; 26(1): 107-10.
[44]  Gajdács M, Ábrók M, Lázár A, Burián K. Increasing relevance of Gram-positive cocci in urinary tract infections: A 10-year analysis of their prevalence and resistance trends. Sci Rep. 2020; 10(1): 1-11.
[45]  Kaur N, Sharma S, Malhotra S, Madan P, Hans C. Urinary tract infection: aetiology and antimicrobial resistance pattern in infants from a tertiary care hospital in northern India. J Clin diagnostic Res JCDR. 2014; 8(10): DC01.
[46]  Nguefack CT, Ebongue CO, Chokotheu CN, Ewougo CE, Njamen TN, Mboudou E. Clinical presentation, risk factors and pathogens involved in bacteriuria of pregnant women attending antenatal clinic of 3 hospitals in a developing country: a cross sectional analytic study. BMC Pregnancy Childbirth. 2019; 19(1): 143.
[47]  Baraboutis IG, Tsagalou EP, Lepinski JL, Papakonstantinou I, Papastamopoulos V, Skoutelis AT, et al. Primary Staphylococcus aureus urinary tract infection: the role of undetected hematogenous seeding of the urinary tract. Eur J Clin Microbiol Infect Dis. 2010; 29(9): 1095-101.
[48]  Al-Ali SM, Al-Faraj JM, Al-Muslim SS. Antimicrobial resistance pattern in urinary tract pathogens and its impact on empirical therapy in general practice. Kuwait Med J. 2005; 37: 22-7.
[49]  Haller M, Brandis M, Berner R. Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol. 2004; 19(9): 982-6.
[50]  Sharifian M, Karimi A, Tabatabaei SR, Anvaripour N. Microbial sensitivity pattern in urinary tract infections in children: a single center experience of 1,177 urine cultures. Jpn J Infect Dis. 2006; 59(6): 380.
[51]  Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Disease-a-month. 2003; 49(2): 53-70.
[52]  Ulett KB, Benjamin WH, Zhuo F, Xiao M, Kong F, Gilbert GL, et al. Diversity of group B streptococcus serotypes causing urinary tract infection in adults. J Clin Microbiol. 2009; 47(7): 2055-60.
[53]  Kessous R, Weintraub AY, Sergienko R, Lazer T, Press F, Wiznitzer A, et al. Bacteruria with group-B streptococcus: is it a risk factor for adverse pregnancy outcomes? J Matern Neonatal Med. 2012; 25(10): 1983-6.
[54]  MIC90 RM. isolates from blood and urine to 18 widely used and recently marketed antibiotics. Clin Microbiol Infect. 2004; 10(3).
[55]  Looney AT, Redmond EJ, Davey NM, Daly PJ, Troy C, Carey BF, et al. Methicillin-resistant Staphylococcus aureus as a uropathogen in an Irish setting. Medicine (Baltimore). 2017; 96(14).
[56]  Mansour A, MAHDINEZHAD M, Pourdangchi Z. Study of bacteria isolated from urinary tract infections and determination of their susceptibility to antibiotics. 2009;
[57]  Goudarzi M, Seyedjavadi SS, Goudarzi H, Boromandi S, Ghazi M, Azad M, et al. Characterization of coagulase-negative staphylococci isolated from hospitalized patients in Tehran, Iran. J Paramed Sci Spring. 2014; 5(2): 2008-4978.
[58]  Benzer D, Yavuzcan ÖD, Gürsoy T, Ocalmaz MS, Karatekin G, Ovalı HF. Vancomycin-resistant enterococcus colonization in neonatal intensive care unit: prevention and eradication experience. Mikrobiyol Bul. 2012; 46(4): 682.
[59]  Leclercq R, Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis. 1997; 24(4): 545-54.
[60]  Somily AM, Al-Mohizea MM, Absar MM, Fatani AJ, Ridha AM, Al-Ahdal MN, et al. Molecular epidemiology of vancomycin resistant enterococci in a tertiary care hospital in Saudi Arabia. Microb Pathog. 2016; 97: 79-83.
[61]  Al-Ahdal MN, Abozaid SM, Al-Shammary HF, Bohol MF, Al-Thawadi SI, Al-Jaberi AA, et al. Characterization of Enterococcus faecium isolates and first report of vanB phenotype-vanA genotype incongruence in the Middle East. Eur J Clin Microbiol Infect Dis. 2012; 31(11): 3223-9.